Answer
Yes. Dolutegravir can increase metformin exposure, so glucose control, renal function and metformin treatment may need review.
Sources for this answer
- Dovato 50 mg/300 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.